ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: "AngioDynamics, Inc." (ANGO) Report Updated: May 23, 2016 | Print This Page

Get more stock ratings by Louis Navellier

"AngioDynamics, Inc." (ANGO)

Rating: Sell Volatility: Conservative
Total Grade: D Industry: Health Care Equipment & Supplies
Competitors: ISRG,WST,CEMI,CMN

Stock Analysis

Rating: Monthly View

A
B
C
D
F
May June July August September October November December January February March April

Rating: Weekly View

This Week: D down no change
Last Week: D same no change
Two Weeks Ago: D up no change
service keys

"AngioDynamics, Inc."© quotemedia

Company Profile

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for vascular access, surgery, peripheral vascular disease, and oncology in the United States and internationally. The company provides manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; VenaCure EVLT laser system products for endovascular laser procedures to treat superficial venous diseases; and Sotradecol, a sclerosing drug for treating small uncomplicated varicose veins of the lower extremities. It also offers AngioVac venous drainage system that includes venous drainage cannula for the removal of fresh, soft thrombi, or emboli during extracorporeal bypass; and cardiopulmonary bypass circuit for use in procedures during extracorporeal circulatory support. In addition, the company provides thrombolytic catheters to deliver thrombolytic agents; angiographic products and accessories for use in during peripheral vascular interventional procedures; drainage products, which drain abscesses and other fluid pockets; and micro access sets. Further, it offers peripherally inserted central catheters; ports that are implantable devices for the central venous administration; and dialysis products. Additionally, the company provides radiofrequency ablation products that use radiofrequency energy to provide a minimally invasive approach to ablating solid cancerous or benign tumors; microwave ablation products; and NanoKnife ablation systems for the surgical ablation of soft tissue The company sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, and interventional and surgical oncologists directly, as well as through distributor relationships. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.